Skip to main content
. 2017 Jun 19;108(8):1628–1633. doi: 10.1111/cas.13285

Table 2.

Treatment‐emergent, all‐causality adverse events in ≥3 patients

N = 13 Treatment‐emergent, all‐causality adverse events
All grades n (%) ≥Grade 3 n (%)
Any adverse event 13 (100.0) 7 (53.8)
Dysgeusia 9 (69.2) 0
Constipation 6 (46.2) 0
Decreased appetite 6 (46.2) 0
Muscle spasms 6 (46.2) 0
Pyrexia 6 (46.2) 1 (7.7)
Alopecia 4 (30.8) 0
Blood creatinine phosphokinase increased 3 (23.1) 0
Diarrhea 3 (23.1) 0
Fatigue 3 (23.1) 0
Hypokalemia 3 (23.1) 2 (15.4)
Thrombocytopenia 3 (23.1) 3 (23.1)
Weight decreased 3 (23.1) 0